Latest Close
₹851.15
+0.73%
Connecting…
Day Range
-
Full OHLC pending
Volume
-
Full session data pending
50 DMA
₹1,019.87
200 DMA
₹1,030.05
1 year gain / loss
−₹327.35(-27.78%)
₹1,178.50 → ₹851.15· 2025-10-30 to 2026-10-30
Charting by TradingView
This stock does not satisfy the default swing-support rules at the selected chart endpoint. Its price, volume and moving averages remain available for manual research.
Snapshot 2026-10-31 · Financial period Jun 2026 · Consolidated figures where available
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company operates through a single segment, namely Medical and Healthcare Services. It provides a wide array of services, including advanced cardiac care, lung transplants, prostate laser surgery, orthopedics, oncology, neurosciences, transplants, minimal access metabolic and bariatric surgery, and other services, including obstetrics and gynecology, pediatrics and nephrology. The Company also provides outpatient services, including consultations for a range of ailments, preventive health screenings, and laboratory services, as well as radiology, imaging, and emergency services. The Company has two strategic business units (SBUs): Max Lab and Max@Home. The Company owns and operates approximately 22 healthcare facilities across the Delhi NCR, Haryana, Punjab, Uttarakhand, Maharashtra, and Uttar Pradesh. It also offers diagnostic services to patients outside its network.
Market Cap
₹83,704.68 Cr
P/E
60.65×
Sector 78.49× · below
P/B
7.39×
Sector 3.46× · above
EV / EBITDA
35.14×
Sector 19.96× · above
ROE
13.42%
Sector -30.49%
ROCE
12.97%
Sector 10.87%
ROA
7.78%
Sector 3.92%
Cash Flow / Profit
1.13×
| Period | Revenue | Operating profit | Net profit |
|---|---|---|---|
| Jun 2026 | 2,406.69 +9.9% | 436.31 | 322.96 -5.6% |
| Mar 2026 | 2,190.72 +3.7% | 464.58 | 342.22 +13.7% |
| Dec 2025 | 2,112.9 -2.6% | 364.54 | 300.92 -38.8% |
| Sep 2025 | 2,168.37 | 446.03 | 491.3 |
Dividend
03 Jul 2026 · ₹2